Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8453364 | Leukemia Research | 2018 | 24 Pages |
Abstract
MRD was frequently used in making treatment decisions and in estimating prognosis. However, there was lack of uniformity in these practices. Standardization of assays, adoption of requisite technology, and dissemination of data about the value of MRD use would likely increase usage of MRD in the care of patients with AML.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zachary D. Epstein-Peterson, Sean M. Devlin, Eytan M. Stein, Elihu Estey, Martin S. Tallman,